OVARIAN CANCER and US: NIH

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label NIH. Show all posts
Showing posts with label NIH. Show all posts

Friday, June 25, 2010

Guest Blog: A genome story: 10th anniversary commentary by Francis Collins



".....Already, in its pilot phase, this NIH-supported project has produced comprehensive molecular classification systems for ovarian cancer and glioblastoma, which is the most common form of brain cancer. This information may help doctors do a better job of matching individual patients with the therapies that are most likely to work well for them. What's more, the findings may lead to new therapies directed at the molecular changes underlying various subtypes of cancer.

Some of this is already happening today...."

Monday, April 19, 2010

A Tweak to the Figures - falsifying data and figures



"The Scientist notes that the papers that include the falsified figures, which appeared in Endocrinology and Molecular Endocrinology, are in the process of being retracted. Writedit also reports that a former Wyeth researcher, Boris Cheskis, has accepted to a two-year agreement after Office of Research Integrity found that he falsified figures submitted to NIH."

Wednesday, March 24, 2010

NIH Announces Genetic Testing Registry, March 18, 2010 News Release - National Institutes of Health (NIH)



NIH Announces Genetic Testing Registry
Database to Fill Information Gaps and Serve as Research Resource

The National Institutes of Health announced today that it is creating a public database that researchers, consumers, health care providers, and others can search for information submitted voluntarily by genetic test providers. The Genetic Testing Registry (GTR) aims to enhance access to information about the availability, validity, and usefulness of genetic tests. More information about the Genetic Testing Registry and NCBI is available at: http://www.ncbi.nlm.nih.gov/gtr/.

Wednesday, January 27, 2010

Search Results: ovarian



simple search: 'ovarian' = 23 references

quick search - ovarian cancer - Clinical Research as at 1/28/2010 9:51 pm EST



There are 5 clinical trials at NIH that match your search criteria
Cancer by type/disease: Ovarian Cancer 

A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer

 A Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian, Fallopian, and Peritoneal Cancer Clinical, Genetic, Behavioral, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

A Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281 (KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in BRCA 1/2 Mutation Carriers, Familial Breast and Ovarian Cancer, and Sporadic Triple Negative Breast Cancer and Ovarian Cancer 

A Phase I, Open-Label Study of MEDI-547 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous Administration in Subjects With Refractory Solid Tumors Associated With EphA2 Expression

A Phase I Study of Dasatinib in Combination With Bevacizumab in Advanced Solid Tumors

Clinical Trials at NIH: Clinical Research: Clinical Trials by Cancer Site